To determine whether disruption of the SP-A:MYADM interaction would affect the resolution of eosinophilia after in vivo experimental allergen challenge, wild-type mice were challenged with OVA or sterile saline and were given anti-MYADM via oropharyngeal delivery one day after terminal challenge (Fig. 4A). This evidence concerns the gene SFTPA2 and Increased total eosinophil count.